Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Fabian Hamacher, Yi-Chin Lee and Ann Wang TAIPEI, June 27 (Reuters) - Mandopop megastar…
By Fabian Hamacher, Yi-Chin Lee and Ann Wang TAIPEI, June 27 (Reuters) - Mandopop megastar…
New Delhi [India], June 26: Reinforcing its commitment to environmental sustainability and responsible corporate citizenship, KAI…
Mumbai (Maharashtra) [India], June 26: The finance sector is going through unprecedented changes right now;…
Inside the cockpit of a Piper Archer DX, at Chimes Aviation Academy. Gurugram (Haryana) [India],…
Kathmandu [Nepal], June 26: Only a few professionals can excel at both clinical practice and…